184 related articles for article (PubMed ID: 16298740)
21. Counteracting adriamycin-induced oxidative stress by administration of N-acetyl cysteine and vitamin E.
Kalaiselvi P; Pragasam V; Chinnikrishnan S; Veena CK; Sundarapandiyan R; Varalakshmi P
Clin Chem Lab Med; 2005; 43(8):834-40. PubMed ID: 16201893
[TBL] [Abstract][Full Text] [Related]
22. Curcumin attenuation of acute adriamycin myocardial toxicity in rats.
Venkatesan N
Br J Pharmacol; 1998 Jun; 124(3):425-7. PubMed ID: 9647462
[TBL] [Abstract][Full Text] [Related]
23. Plantainoside D protects adriamycin-induced apoptosis in H9c2 cardiac muscle cells via the inhibition of ROS generation and NF-kappaB activation.
Kim DS; Woo ER; Chae SW; Ha KC; Lee GH; Hong ST; Kwon DY; Kim MS; Jung YK; Kim HM; Kim HK; Kim HR; Chae HJ
Life Sci; 2007 Jan; 80(4):314-23. PubMed ID: 17034819
[TBL] [Abstract][Full Text] [Related]
24. Redox proteomic identification of oxidized cardiac proteins in adriamycin-treated mice.
Chen Y; Daosukho C; Opii WO; Turner DM; Pierce WM; Klein JB; Vore M; Butterfield DA; St Clair DK
Free Radic Biol Med; 2006 Nov; 41(9):1470-7. PubMed ID: 17023274
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of the cardioprotective effects of docetaxel pre-administration against adriamycin-induced cardiotoxicity.
Tomonari M; To H; Nishida M; Mishima T; Sasaki H; Kurose H
J Pharmacol Sci; 2011; 115(3):336-45. PubMed ID: 21358119
[TBL] [Abstract][Full Text] [Related]
26. Oxidatively modified GST and MRP1 in Alzheimer's disease brain: implications for accumulation of reactive lipid peroxidation products.
Sultana R; Butterfield DA
Neurochem Res; 2004 Dec; 29(12):2215-20. PubMed ID: 15672542
[TBL] [Abstract][Full Text] [Related]
27. The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.
Butterfield DA
Free Radic Biol Med; 2014 Sep; 74():157-74. PubMed ID: 24996204
[TBL] [Abstract][Full Text] [Related]
28. Global effects of adriamycin treatment on mouse splenic protein levels.
Evans AR; Miriyala S; St Clair DK; Butterfield DA; Robinson RA
J Proteome Res; 2012 Feb; 11(2):1054-64. PubMed ID: 22112237
[TBL] [Abstract][Full Text] [Related]
29. Impact of ellagic acid on adriamycin-induced testicular histopathological lesions, apoptosis, lipid peroxidation and sperm damages.
Çeribaşı AO; Sakin F; Türk G; Sönmez M; Ateşşahin A
Exp Toxicol Pathol; 2012 Nov; 64(7-8):717-24. PubMed ID: 21295454
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of free radical effects and catecholamine alterations in adriamycin cardiotoxicity.
Jackson JA; Reeves JP; Muntz KH; Kruk D; Prough RA; Willerson JT; Buja LM
Am J Pathol; 1984 Oct; 117(1):140-53. PubMed ID: 6486242
[TBL] [Abstract][Full Text] [Related]
31. Protection against Adriamycin cytotoxicity and inhibition of DNA topoisomerase II activity by 3,4-dihydroxybenzoic acid.
De Graff WG; Myers LS; Mitchell JB; Hahn SM
Int J Oncol; 2003 Jul; 23(1):159-63. PubMed ID: 12792789
[TBL] [Abstract][Full Text] [Related]
32. Propionyl-L-carnitine as potential protective agent against adriamycin-induced impairment of fatty acid beta-oxidation in isolated heart mitochondria.
Sayed-Ahmed MM; Shouman SA; Rezk BM; Khalifa MH; Osman AM; El-Merzabani MM
Pharmacol Res; 2000 Feb; 41(2):143-50. PubMed ID: 10623482
[TBL] [Abstract][Full Text] [Related]
33. The protective effect of melatonin on adriamycin-induced acute cardiac injury.
Koçak G; Erbil KM; Ozdemir I; Aydemir S; Sunar B; Tuncel M; Atalay S
Can J Cardiol; 2003 Apr; 19(5):535-41. PubMed ID: 12717489
[TBL] [Abstract][Full Text] [Related]
34. Transfection of a 4-hydroxynonenal metabolizing glutathione S-transferase isozyme, mouse GSTA4-4, confers doxorubicin resistance to Chinese hamster ovary cells.
He NG; Singhal SS; Srivastava SK; Zimniak P; Awasthi YC; Awasthi S
Arch Biochem Biophys; 1996 Sep; 333(1):214-20. PubMed ID: 8806773
[TBL] [Abstract][Full Text] [Related]
35. Adriamycin affects glomerular renal function: evidence for the involvement of oxygen radicals.
Barbey MM; Fels LM; Soose M; Poelstra K; Gwinner W; Bakker W; Stolte H
Free Radic Res Commun; 1989; 7(3-6):195-203. PubMed ID: 2531111
[TBL] [Abstract][Full Text] [Related]
36. Mrp1 localization and function in cardiac mitochondria after doxorubicin.
Jungsuwadee P; Nithipongvanitch R; Chen Y; Oberley TD; Butterfield DA; St Clair DK; Vore M
Mol Pharmacol; 2009 May; 75(5):1117-26. PubMed ID: 19233900
[TBL] [Abstract][Full Text] [Related]
37. Phenylbutyrate, a histone deacetylase inhibitor, protects against Adriamycin-induced cardiac injury.
Daosukho C; Chen Y; Noel T; Sompol P; Nithipongvanitch R; Velez JM; Oberley TD; St Clair DK
Free Radic Biol Med; 2007 Jun; 42(12):1818-25. PubMed ID: 17512461
[TBL] [Abstract][Full Text] [Related]
38. A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo.
Mookerjee A; Basu JM; Majumder S; Chatterjee S; Panda GS; Dutta P; Pal S; Mukherjee P; Efferth T; Roy S; Choudhuri SK
BMC Cancer; 2006 Nov; 6():267. PubMed ID: 17107616
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity.
Shioji K; Kishimoto C; Nakamura H; Masutani H; Yuan Z; Oka S; Yodoi J
Circulation; 2002 Sep; 106(11):1403-9. PubMed ID: 12221060
[TBL] [Abstract][Full Text] [Related]
40. Protective effect of unsymmetrical dichalcogenide, a novel antioxidant agent, in vitro and an in vivo model of brain oxidative damage.
Prigol M; Wilhelm EA; Schneider CC; Nogueira CW
Chem Biol Interact; 2008 Nov; 176(2-3):129-36. PubMed ID: 18722362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
